Published in Gene Ther on July 01, 1995
Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A (2003) 2.12
New insights into type II NAD(P)H:quinone oxidoreductases. Microbiol Mol Biol Rev (2004) 1.68
Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc Natl Acad Sci U S A (1998) 1.49
Mismatch repair activity in mammalian mitochondria. Nucleic Acids Res (2003) 1.24
Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res (2001) 1.23
NADH dehydrogenases: from basic science to biomedicine. J Bioenerg Biomembr (2001) 0.88
Treatment of mitochondrial disease. J Bioenerg Biomembr (1997) 0.87
Assessing the Delivery of Molecules to the Mitochondrial Matrix Using Click Chemistry. Chembiochem (2016) 0.81
Linked oligodeoxynucleotides show binding cooperativity and can selectively impair replication of deleted mitochondrial DNA templates. Nucleic Acids Res (2001) 0.76
ClickIn: a flexible protocol for quantifying mitochondrial uptake of nucleobase derivatives. Interface Focus (2017) 0.75
Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet (1999) 18.22
Multi-system neurological disease is common in patients with OPA1 mutations. Brain (2010) 5.37
Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol (2001) 3.00
Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet (1991) 2.70
The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet (2002) 2.67
Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet (1997) 2.45
Leber hereditary optic neuropathy. J Med Genet (2002) 2.33
Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am J Hum Genet (2001) 2.31
Somatic mitochondrial DNA mutations in adult-onset leukaemia. Leukemia (2003) 2.26
The pedigree rate of sequence divergence in the human mitochondrial genome: there is a difference between phylogenetic and pedigree rates. Am J Hum Genet (2003) 2.23
The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol (2000) 2.20
The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both? Trends Genet (2000) 2.19
The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations. Nucleic Acids Res (2001) 2.17
Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain (1997) 2.09
Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol (1998) 2.08
Transmission of mitochondrial DNA disorders: possibilities for the future. Lancet (2006) 2.05
Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology (2005) 2.01
Random genetic drift determines the level of mutant mtDNA in human primary oocytes. Am J Hum Genet (2000) 1.89
Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology (2006) 1.87
Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med (2008) 1.82
Comparative genomics and the evolution of human mitochondrial DNA: assessing the effects of selection. Am J Hum Genet (2004) 1.80
Peptide nucleic acid delivery to human mitochondria. Gene Ther (1999) 1.77
Mitochondrial gene segregation in mammals: is the bottleneck always narrow? Hum Genet (1992) 1.77
MELAS associated with mutations in the POLG1 gene. Neurology (2007) 1.77
An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol (1994) 1.74
Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care (1994) 1.68
A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet (1997) 1.68
Mitochondrial disease--its impact, etiology, and pathology. Curr Top Dev Biol (2007) 1.64
Mitochondrial medicine. QJM (1997) 1.58
Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet (1997) 1.53
Analysis of European mtDNAs for recombination. Am J Hum Genet (2000) 1.51
Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol (1999) 1.46
Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology (2003) 1.43
Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain (1995) 1.42
Can paternal mtDNA be inherited? Lancet (2000) 1.41
Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology (1994) 1.41
No evidence of an association between the T16189C mtDNA variant and late onset dementia. J Med Genet (2004) 1.40
Effects of physical activity and age on mitochondrial function. QJM (1996) 1.39
A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype. J Pediatr (1998) 1.39
Recurrent strokes in a 34-year-old man. Lancet (1997) 1.39
Which drug for the adult epileptic patient: phenytoin or valproate? Br Med J (Clin Res Ed) (1985) 1.36
The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology (2010) 1.36
Mutations of the mitochondrial ND1 gene as a cause of MELAS. J Med Genet (2004) 1.35
Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene. Ann Neurol (2000) 1.35
Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation. Neurology (2009) 1.35
Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat Genet (1997) 1.34
A partial deficiency of cytochrome c oxidase in chronic progressive external ophthalmoplegia. J Neurol Sci (1983) 1.34
Cytochrome c oxidase deficient cells accumulate in the hippocampus and choroid plexus with age. Neurobiol Aging (2001) 1.33
Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation? Am J Med Genet (2001) 1.33
Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism. J Biol Chem (1993) 1.31
Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol (2006) 1.29
MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain (1998) 1.26
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res (1991) 1.25
The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol (2004) 1.25
Mitochondrial abnormalities in ageing macular photoreceptors. Invest Ophthalmol Vis Sci (2001) 1.25
Epidemiology and treatment of mitochondrial disorders. Am J Med Genet (2001) 1.23
Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res (2001) 1.23
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology (2000) 1.22
Nonrandom tissue distribution of mutant mtDNA. Am J Med Genet (1999) 1.22
Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. J Neurol Neurosurg Psychiatry (1984) 1.22
Sequence variation in mitochondrial complex I genes: mutation or polymorphism? J Med Genet (2005) 1.20
Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest (1992) 1.20
Mitochondrial function in Parkinson's disease. Lancet (1989) 1.20
Age-related decline in mitochondrial DNA copy number in isolated human pancreatic islets. Diabetologia (2008) 1.19
Clinical features, investigation, and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry (1997) 1.18
The mitochondrial ND6 gene is a hot spot for mutations that cause Leber's hereditary optic neuropathy. Brain (2001) 1.18
Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency. N Engl J Med (1984) 1.18
Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology (2001) 1.17
74th ENMC international workshop: mitochondrial diseases 19-20 november 1999, Naarden, the netherlands. Neuromuscul Disord (2000) 1.16
Inhibition of mitochondrial protein synthesis promotes increased stability of nuclear-encoded respiratory gene transcripts. J Biol Chem (1994) 1.15
Mitochondrial DNA analysis: polymorphisms and pathogenicity. J Med Genet (1999) 1.12
Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J Neurol Sci (1991) 1.12
Progress and prospects: gene therapy for mitochondrial DNA disease. Gene Ther (2008) 1.12
Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br J Ophthalmol (1999) 1.11
Intracellular mitochondrial triplasmy in a patient with two heteroplasmic base changes. Am J Hum Genet (1997) 1.11
Identification of the NAD(+)-binding fold of glyceraldehyde-3-phosphate dehydrogenase as a novel RNA-binding domain. Biochem Biophys Res Commun (2000) 1.10
Restriction enzyme analysis of the mitochondrial genome in mitochondrial myopathy. J Med Genet (1988) 1.10
A comparison of phenytoin and valproate in previously untreated adult epileptic patients. J Neurol Neurosurg Psychiatry (1982) 1.09
An mtDNA mutation in the initiation codon of the cytochrome C oxidase subunit II gene results in lower levels of the protein and a mitochondrial encephalomyopathy. Am J Hum Genet (1999) 1.08
POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Neurology (2006) 1.08
Fatal lactic acidosis in infancy with a defect of complex III of the respiratory chain. Pediatr Res (1989) 1.08
Clinical mitochondrial genetics. J Med Genet (1999) 1.08
Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet. Neuropediatrics (1992) 1.07
Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene. Ann Neurol (2001) 1.07